Mark E. Robson, MD

About Me

I am a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. As Clinic Director of the Clinical Genetics Service, I concentrate on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, I work to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs. Along the same lines, my research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types.

Read more

Consistent with the goals I pursue in my clinical genetics work, my oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, I participate in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, I also maintain a separate practice where I coordinate screening for women with mutations in BRCA1 or BRCA2.

  • Clinical Expertise: General Hematology/Oncology; Breast Cancer; Genetic Predisposition to Cancer; Cancer Risk Counseling
  • Languages Spoken: English
  • Education: MD, University of Virginia School of Medicine
  • Residencies: Walter Reed Army Medical Center
  • Fellowships: Walter Reed Army Medical Center
  • Board Certifications: Internal Medicine; Medical Oncology; Hematology

My Research

View my lab

See Mark E. Robson’s laboratory
research at Memorial Sloan Kettering.

Publications

Visit PubMed for a full listing of Mark E. Robson’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.